Guiyang Longmaster Information & Technology Co Ltd is an internet service company in the field of medical health. The company's health network operates a medical health vertical portal website, providing medical information and online consultation services. In addition, the company operates a telephone voice community telephone with internet thinking.
1998
874
LTM Revenue n/a
LTM EBITDA n/a
$589M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Guiyang Longmaster has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Guiyang Longmaster achieved revenue of $63.3M and an EBITDA of $17.6M.
Guiyang Longmaster expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Guiyang Longmaster valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $63.3M | n/a | XXX | XXX | XXX |
Gross Profit | $22.3M | $22.7M | XXX | XXX | XXX |
Gross Margin | 35% | NaN% | XXX | XXX | XXX |
EBITDA | $17.6M | n/a | XXX | XXX | XXX |
EBITDA Margin | 28% | NaN% | XXX | XXX | XXX |
Net Profit | $8.8M | $9.7M | XXX | XXX | XXX |
Net Margin | 14% | NaN% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Guiyang Longmaster's stock price is CNY 13 (or $2).
Guiyang Longmaster has current market cap of CNY 4.5B (or $623M), and EV of CNY 4.3B (or $589M).
See Guiyang Longmaster trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$589M | $623M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Guiyang Longmaster has market cap of $623M and EV of $589M.
Guiyang Longmaster's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Guiyang Longmaster's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Guiyang Longmaster and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $589M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpGuiyang Longmaster's NTM/LTM revenue growth is n/a
Guiyang Longmaster's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $16K for the same period.
Over next 12 months, Guiyang Longmaster's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Guiyang Longmaster's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Guiyang Longmaster and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $16K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
Opex to Revenue | 22% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Guiyang Longmaster acquired XXX companies to date.
Last acquisition by Guiyang Longmaster was XXXXXXXX, XXXXX XXXXX XXXXXX . Guiyang Longmaster acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Guiyang Longmaster founded? | Guiyang Longmaster was founded in 1998. |
Where is Guiyang Longmaster headquartered? | Guiyang Longmaster is headquartered in China. |
How many employees does Guiyang Longmaster have? | As of today, Guiyang Longmaster has 874 employees. |
Is Guiyang Longmaster publicy listed? | Yes, Guiyang Longmaster is a public company listed on SHE. |
What is the stock symbol of Guiyang Longmaster? | Guiyang Longmaster trades under 300288 ticker. |
When did Guiyang Longmaster go public? | Guiyang Longmaster went public in 2012. |
Who are competitors of Guiyang Longmaster? | Similar companies to Guiyang Longmaster include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Guiyang Longmaster? | Guiyang Longmaster's current market cap is $623M |
Is Guiyang Longmaster profitable? | Yes, Guiyang Longmaster is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.